A novel mechanism of sequestering tumor suppressor mRNAs reveals new therapeutic vulnerabilities in leukemic cells.
Get full access to this article
View all access options for this article.
References
1.
FranksTM, Lykke-AndersenJ. The control of mRNA decapping and P-Body formation. Mol Cell, 2008; 32(5):605–615; doi: 10.1016/j.molcel.2008.11.001
2.
Van GalenP, HovestadtV, WadsworthMH, et al.Single-Cell RNA-Seq reveals AML hierarchies relevant to disease progression and immunity. Cell, 2019; 176(6):1265–1281.e24; doi: 10.1016/j.cell.2019.01.031Ii
3.
HardySD, ShindeA, WangW-H, et al.Regulation of epithelial-mesenchymal transition and metastasis by TGF-β, P-Bodies, and autophagy. Oncotarget, 2017; 8(61):103302–103314; doi: 10.18632/oncotarget.21871
4.
KodaliS, ProiettiL, ValcarcelG, et al.RNA sequestration in P-Bodies sustains myeloid leukemia. Nat Cell Biol, 2024; 26(10):1745–1758; doi: 10.1038/s41556-024-01489-6
5.
LittleEC, CampER, WangC, et al.The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells. Oncogenesis, 2016; 5(1):e182–e182; doi: 10.1038/oncsis.2015.45
NsengimanaB, KhanFA, NgowiEE, et al.Processing Body (P-Body) and its mediators in cancer. Mol Cell Biochem, 2022; 477(4):1217–1238; doi: 10.1007/s11010-022-04359-7
8.
ParkerR, ShethU. P bodies and the control of mRNA translation and degradation. Mol Cell, 2007; 25(5):635–646; doi: 10.1016/j.molcel.2007.02.011
9.
RenZ, KimA, HuangY-T, et al.A PRC2-Kdm5b axis sustains tumorigenicity of acute myeloid leukemia. Proc Natl Acad Sci USA, 2022; 119(9); doi: 10.1073/pnas.2122940119
10.
SafieddineA, BenassyM-N, BonteT, et al.Cell-Cycle-Dependent mRNA localization in P-Bodies. Mol Cell, 2024; 84(21):4191–4208.e7; doi: 10.1016/j.molcel.2024.09.011
TakahashiS, SuzukiS, InagumaS, et al.Down-Regulation of Lsm1 is involved in human prostate cancer progression. Br J Cancer, 2002; 86(6):940–946; doi: 10.1038/sj.bjc.6600163
13.
XuJ, SongF, LyuH, et al.Subtype-Specific 3D genome alteration in acute myeloid leukemia. Nature, 2022; 611(7935):387–398; doi: 10.1038/s41586-022-05365-x